The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?
Open accessAbstract
Carboxylesterases are a multigene family of mammalian enzymes widely distributed throughout the body that catalyze the hydrolysis of esters, amides, thioesters, and carbamates. In humans, two carboxylesterases, hCE 1 and hCE 2, are important mediators of drug metabolism. Both are expressed in the liver, but hCE 1 greatly exceeds hCE 2. In the intestine, only hCE 2 is present and highly expressed. The most common drug substrates of these enzymes are ester prodrugs specifically designed to enhance oral bioavailability by hydrolysis to the active carboxylic acid after absorption from the gastrointestinal tract. Carboxylesterases also play an important role in the hydrolysis of some drugs to inactive metabolites. It has been widely believed that drugs undergoing hydrolysis by hCE 1 and hCE 2 are not subject to clinically significant alterations in their disposition, but evidence exists that genetic polymorphisms, drug‐drug interactions, drug‐disease interactions and other factors are important determinants of the variability in the therapeutic response to carboxylesterase‐substrate drugs. The implications for drug therapy are far‐reaching, as substrate drugs include numerous examples from widely prescribed therapeutic classes. Representative drugs include angiotensin‐converting enzyme inhibitors, angiotensin receptor blockers, antiplatelet drugs, statins, antivirals, and central nervous system agents. As research interest increases in the carboxylesterases, evidence is accumulating of their important role in drug metabolism and, therefore, the outcomes of pharmacotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE MAMMALIAN CARBOXYLESTERASES: From Molecules to Functions
Satoh, T., & Hosokawa, M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.257 · Cited by 758
The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans
Blech, S., Ebner, T., Ludwig-Schwellinger, E., Stangier, J., & Roth, W. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.019083 · Cited by 689
Structure, function and regulation of carboxylesterases
Satoh, T., & Hosokawa, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.07.001 · Cited by 488
Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802
He, G., Massarella, J., & Ward, P. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937060-00003 · Cited by 410
Farid, N. A., Kurihara, A., & Wrighton, S. A. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009343005 · Cited by 397
Hosokawa, M. (2008) · Molecules · doi:10.3390/molecules13020412 · Cited by 382
Structure, Function, and Regulation of Carboxylesterases
Hosokawa, M., & Satoh, T. (2006) · Toxicology of Organophosphate & Carbamate Compounds · doi:10.1016/b978-012088523-7/50017-x · Cited by 374
Human Carboxylesterase Isozymes: Catalytic Properties and Rational Drug Design
Imai, T. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.173 · Cited by 359
Current Progress on Esterases: From Molecular Structure to Function
Satoh, T., Taylor, P., Bosron, W. F., Sanghani, S. P., Hosokawa, M., & Du, B. N. L. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.5.488 · Cited by 295
Shi, D., Yang, J., Yang, D., LeCluyse, E. L., Black, C., Li, Y., Akhlaghi, F., & Yan, B. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111807 · Cited by 279
Xu, G. H., Zhang, W., Ma, M. K., & McLeod, H. L. (2002) · PubMed · Cited by 277
Imai, T., Taketani, M., Shii, M., Hosokawa, M., & Chiba, K. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.009381 · Cited by 275
Perucca, E., Cloyd, J. C., Critchley, D. J. P., & Fuseau, E. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01665.x · Cited by 260
Tang, M., Mukundan, M., Yang, J., Charpentier, N., LeCluyse, E. L., Black, C., Yang, D., Shi, D., & Yan, B. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110577 · Cited by 250
Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug.
Vickers, S., Duncan, C. A., Chen, I. W., Rosegay, A., & Duggan, D. E. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07595-6 · Cited by 246
Zhu, H.-J., Patrick, K. S., Yuan, H.-J., Wang, J.-S., Donovan, J. L., DeVane, C. L., Malcolm, R., Johnson, J. A., Youngblood, G. L., Sweet, D. H., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.04.015 · Cited by 229
Pharmacology of the enantiomers of threo-methylphenidate.
Patrick, K. S., Caldwell, R. W., Ferris, R. M., & Breese, G. R. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00340-4 · Cited by 196
Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases.
Kamendulis, L. M., Brzezinski, M. R., Pindel, E. V., Bosron, W. F., & Dean, R. A. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21180-6 · Cited by 190
Methylphenidate Is Stereoselectively Hydrolyzed by Human Carboxylesterase CES1A1
Sun, Z., Murry, D. J., Sanghani, S. P., Davis, W. I., Kedishvili, N. Y., Zou, Q., Hurley, T. D., & Bosron, W. F. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.067116 · Cited by 187
Quinney, S. K., Sanghani, S. P., Davis, W. I., Hurley, T. D., Sun, Z., Murry, D. J., & Bosron, W. F. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081265 · Cited by 184
Holmes, R. S., Wright, M. W., Laulederkind, S. J. F., Cox, L. A., Hosokawa, M., Imai, T., Ishibashi, S., Lehner, R., Miyazaki, M., Perkins, E. J., et al. (2010) · Mammalian Genome · doi:10.1007/s00335-010-9284-4 · Cited by 180
SATOH, T., HOSOKAWA, M., ATSUMI, R., SUZUKI, W., HAKUSUI, H., & NAGAI, E. (1994) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.17.662 · Cited by 174
Human carboxylesterases and their role in xenobiotic and endobiotic metabolism
Ross, M. K., & Crow, J. A. (2007) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20178 · Cited by 169
Yang, D., Pearce, R. E., Wang, X., Gaedigk, R., Wan, Y.-J. Y., & Yan, B. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.10.005 · Cited by 167
Prodrugs of nucleoside analogues for improved oral absorption and tissue targeting
Li, F., Maag, H., & Alfredson, T. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21047 · Cited by 155
In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.
Vickers, S., Duncan, C. A., Vyas, K. P., Kari, P. H., Arison, B. H., Prakash, S. R., Ramjit, H. G., Pitzenberger, S. M., Stokker, G. E., & Duggan, D. E. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08543-5 · Cited by 154
The pharmacology of cocaethylene in humans following cocaine and ethanol administration
Harris, D. S., Everhart, E. T., Mendelson, J. E., & Jones, R. T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00200-x · Cited by 151
Sanghani, S. P., Quinney, S. K., Fredenburg, T. B., Davis, W. I., Murry, D. J., & BOSRON, W. F. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.5.505 · Cited by 145
Influence of Ethanol and Gender on Methylphenidate Pharmacokinetics and Pharmacodynamics
Patrick, K. S., Straughn, A. B., Minhinnett, R., Yeatts, S. D., Herrin, A. E., DeVane, C. L., Malcolm, R. J., Janis, G. C., & Markowitz, J. S. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100082 · Cited by 137
Human Carboxylesterases: An Update on CES1, CES2 and CES3
Sanghani, S. P., Sanghani, P. C., Schiel, M. A., & BOSRON, W. F. (2009) · Protein and Peptide Letters · doi:10.2174/092986609789071324 · Cited by 135
Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats.
Chu, X., Kato, Y., & Sugiyama, Y. (1997) · PubMed · Cited by 129
Williams, E. T., Jones, K. O., Ponsler, G. D., Lowery, S. M., Perkins, E. J., Wrighton, S. A., Ruterbories, K. J., Kazui, M., & Farid, N. A. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.020248 · Cited by 128
Tong, L., Phan, T. K., Robinson, K. L., Babusis, D. M., Strab, R., Bhoopathy, S., Hidalgo, I. J., Rhodes, G. R., & Ray, A. S. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00671-07 · Cited by 124
Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysis.
Sanghani, S. P., Quinney, S. K., Fredenburg, T. B., Sun, Z., Davis, W. I., Murry, D. J., Cummings, O. W., Seitz, D. E., & BOSRON, W. F. (2003) · PubMed · Cited by 122
Human carboxylesterase 1: from drug metabolism to drug discovery
Redinbo, M. R., Bencharit, S., & Potter, P. M. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310620 · Cited by 110
Interindividual variation in carboxylesterase levels in human liver microsomes.
Hosokawa, M., Endo, T., Fujisawa, M., Hara, S., Iwata, N., Sato, Y. Z., & Satoh, T. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06743-1 · Cited by 103
Binding and Hydrolysis of Meperidine by Human Liver Carboxylesterase hCE-1
Zhang, J., Burnell, J. C., Dumaual, N. G., & BOSRON, W. F. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34901-8 · Cited by 101
Geshi, E., Kimura, T., YOSHIMURA, M., Suzuki, H., Koba, S., Sakai, T., Saito, T., Atsuro, K. O. G. A., Muramatsu, M., & Katagiri, T. (2005) · Hypertension Research · doi:10.1291/hypres.28.719 · Cited by 96
Hatfield, M. J., Tsurkan, L. G., Garrett, M. R., Shaver, T. M., Hyatt, J. L., Edwards, C. C., Hicks, L. D., & Potter, P. M. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.09.001 · Cited by 95
Sugiyama, Y., Kato, Y., & Chu, X. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051078 · Cited by 95
Age- and Sex-Related Expression and Activity of Carboxylesterase 1 and 2 in Mouse and Human Liver
Zhu, H., Appel, D. I., Jiang, Y., et al. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.028209 · Cited by 94
Pharmacologic, Pharmacokinetic, and Therapeutic Differences among ACE Inhibitors
White, C. M. (1998) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03121.x · Cited by 91
Cocaethylene Metabolism and Interaction with Cocaine and Ethanol: Role of Carboxylesterases
Laizure, S. C., Mandrell, T. D., Gades, N. M., & Parker, R. B. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.1.16 · Cited by 87
Self-citationZhu, H., & Markowitz, J. S. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024943 · Cited by 87
de Wildt, S. N. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.577739 · Cited by 83
Carboxylesterase 1 gene polymorphism and methylphenidate response in ADHD
Nemoda, Z., Angyal, N., Tárnok, Z., Gádoros, J., & Sasvári‐Székely, M. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.014 · Cited by 81
Role of carboxylesterase 1 and impact of natural genetic variants on the hydrolysis of trandolapril
Zhu, H., Appel, D. I., Johnson, J. A., Chavin, K. D., & Markowitz, J. S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.12.017 · Cited by 72
Nuclear receptor-mediated regulation of carboxylesterase expression and activity
Staudinger, J. L., Xu, C., Cui, Y. J., & Klaassen, C. D. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250903483215 · Cited by 72
Cocaethylene formation following ethanol and cocaine administration by different routes.
Herbst, E. D., Harris, D. S., Everhart, E. T., Mendelson, J. E., Jacob, P., & Jones, R. T. (2011) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0022950 · Cited by 69
Esterase Inhibition by Grapefruit Juice Flavonoids Leading to a New Drug Interaction
Li, P., Callery, P. S., Gan, L.-S. L., & Balani, S. K. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013904 · Cited by 69
Blais, D. R., Lyn, R. K., Joyce, M., Rouleau, Y., Steenbergen, R. D. M., Barsby, N. L., Zhu, L.-F., Pegoraro, A. F., Stolow, A., Tyrrell, D., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.135483 · Cited by 66
Ishizuka, T., Fujimori, I., Kato, M., Noji-Sakikawa, C., Saito, M., Yoshigae, Y., Kubota, K., Kurihara, A., Izumi, T., Ikeda, T., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.072629 · Cited by 63
Kinetics of methylprednisolone and its hemisuccinate ester
Derendorf, H., Möllmann, H., Rohdewald, P. J., et al. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.79 · Cited by 59
Roberts, S. M., Harbison, R. D., & James, R. C. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07412-4 · Cited by 57
Shi, D., Yang, D., Prinssen, E. P. M., Davies, B. E., & Yan, B. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq145 · Cited by 57
Halpin, R. A., Ulm, E. H., Till, A. E., Kari, P. H., Vyas, K. P., Hunninghake, D. B., & Duggan, D. E. (1993) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08192-9 · Cited by 54
Candesartan cilexetil: a review of its preclinical pharmacology.
Nishikawa, K., Naka, T., Chatani, F., et al. (1997) · PubMed · Cited by 54
Vistoli, G., Pedretti, A., Mazzolari, A., et al. (2010) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-010-9373-1 · Cited by 53
Parker, R. B., & Laizure, S. C. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.030056 · Cited by 44
Self-citationFurihata, T., Hosokawa, M., Fujii, A., Derbel, M., Satoh, T., & Chiba, K. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.01.017 · Cited by 42
Determination of Drug Interactions Occurring with the Metabolic Pathways of Irinotecan
Charasson, V., Haaz, M., & Robert, J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.6.731 · Cited by 39
Vree, T. B., Dammers, E., Ulč, I., Horkovics-Kovats, S., Ryska, M., & Merkx, I. (2003) · The Scientific World JOURNAL · doi:10.1100/tsw.2003.121 · Cited by 32
Srinivas, N. R., Hubbard, J. W., Korchinski, E. D., & Midha, K. K. (1992) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600810805 · Cited by 25
Liu, R., Tam, T. W., Mao, J., et al. (2010) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3zp42 · Cited by 24
A comparison of the metabolism of clopidogrel and prasugrel
Laizure, S. C., & Parker, R. B. (2010) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2010.519334 · Cited by 17
Self-citationGodfrey, A. R., DiGiacinto, J. L., & Davis, M. W. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.05.047 · Cited by 14
Human Liver Cocaine Carboxylesterases
BOSRON, W. F., Dean, R. A., Brzezinski, M. R., & Pindel, E. V. (1997) · PsycEXTRA Dataset · doi:10.1037/e495572006-004 · Cited by 8
Procainamide and Quinidine Inhibition of the Human Hepatic Degradation of Meperidine In Vitro
Bailey, D. N., & Briggs, J. R. (2003) · Journal of Analytical Toxicology · doi:10.1093/jat/27.3.142 · Cited by 5
Cited by
The expanding role of prodrugs in contemporary drug design and development
Rautio, J., Meanwell, N. A., Di, L., & Hageman, M. J. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.46 · Cited by 767
Human carboxylesterases: a comprehensive review
Wang, D., Zou, L., Jin, Q., Hou, J., Ge, G., & Yang, L. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.05.005 · Cited by 543
de Man, F. M., Goey, A. K. L., van Schaik, R. H. N., Mathijssen, R. H. J., & Bins, S. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0644-7 · Cited by 421
Carboxylesterases in lipid metabolism: from mouse to human
Lian, J., Nelson, R., & Lehner, R. (2018) · Protein & Cell · doi:10.1007/s13238-017-0437-z · Cited by 300
Prodrugs in medicinal chemistry and enzyme prodrug therapies
Walther, R., Rautio, J., & Zelikin, A. N. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.013 · Cited by 288
Metadata
- Authors
- Casey Laizure, S., Herring, V., Hu, Z., Witbrodt, K., & Parker, R. B.
- Venue
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Publisher
- Wiley
- Published
- 2013-02
- Volume
- 33
- Issue
- 2
- Pages
- 210-222
- ISSN
- 0277-0008 (ISSN-L)
- 1875-9114
- OpenAlex
- W2131257415
- Cited by
- 446
- References
- 68
- FWCI
- 20.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.